Key Highlights
- ARKQ ETF acquired 33,210 shares of TSLA valued at approximately $11.4M on April 8, 2026
- Cathie Wood’s funds have accumulated $27.8M worth of Tesla stock during the current week
- ARKQ divested 33,812 shares of Teradyne (TER) worth roughly $12.1M following an 11.8% rally
- ARK portfolios also trimmed positions in Roku (ROKU) and Strata Critical Medical
- Tesla maintains a Hold rating consensus on TipRanks with analysts setting a mean price target of $393.97
Cathie Wood’s investment firm continued its Tesla accumulation strategy on Wednesday, April 8, when the ARKQ ETF acquired 33,210 shares valued at approximately $11.4 million. This latest transaction pushes Wood’s total Tesla investments for the week to $27.8 million.
The Wednesday purchase follows two consecutive days of buying that totaled $16.4 million. Wood’s aggressive buying pattern demonstrates unwavering confidence despite the electric vehicle maker’s recent struggles.
Tesla shares have declined 23.7% since the start of the year. Market participants have grown increasingly concerned about the company’s disappointing first-quarter 2026 delivery figures, weakening electric vehicle market demand, and the gradual discontinuation of the classic Model S and Model X lineups.
Chief Executive Elon Musk’s attention spread across numerous business ventures has further dampened investor confidence. Combined with persistent speculation about a potential SpaceX-Tesla combination, the stock has faced significant headwinds.
Wood’s investment thesis centers on the belief that Tesla’s true value lies beyond automobile manufacturing. Her vision positions the company as a technology-focused platform centered on autonomous driving capabilities, with the potential to achieve gross profit margins between 70–80%.
Such margins would align Tesla more closely with software and technology companies than conventional automotive manufacturers. While highly optimistic, Wood has maintained this perspective consistently over multiple years.
ARK Capitalizes on Teradyne Rally
On the disposition front, ARKQ liquidated 33,812 shares of Teradyne (TER) for approximately $12.1 million. The semiconductor equipment company had jumped 11.8% after Goldman Sachs identified it as their preferred semiconductor investment for the market rebound.
ARK evidently capitalized on the price momentum as an exit point, securing profits while continuing to reduce its overall Teradyne exposure.
The firm also disposed of 26,770 shares of Roku (ROKU) distributed across its ARKK and ARKW funds for roughly $2.6 million. This transaction extends ARK’s ongoing trend of systematically reducing its Roku holdings.
Smaller acquisitions included 19,653 shares of Kodiak AI (KDK) totaling $152,310 and 12,516 shares of GeneDx Holdings (WGS) for $837,195. Additionally, ARK decreased its Strata Critical Medical (SRTA) stake by selling 62,882 shares for $255,300.
Tesla’s Semiconductor Manufacturing Initiative
Tesla continues advancing its Terafab facility in Austin, Texas — an ambitious fabrication complex designed to produce 1 terawatt worth of AI processing chips annually.
Intel (INTC) has partnered on the initiative alongside SpaceX and xAI. Intel’s extensive chip engineering and manufacturing capabilities are anticipated to accelerate the timeline and minimize potential construction setbacks.
However, not every market analyst shares enthusiasm for the AI and robotics strategy shift. Tesla currently receives a Hold consensus rating on TipRanks, derived from 13 Buy recommendations, 11 Hold ratings, and 8 Sell opinions.
Analysts have established an average price objective of $393.97, suggesting potential upside of approximately 14.8% from present trading levels.
